The past few years have brought monumental changes to the world of healthcare, significantly impacting independent pharmacies. With the rollback of COVID-era regulations and the continuous introduction of new laws and policies, keeping up with these changes can be a daunting task. However, staying compliant is essential for the success and sustainability of your pharmacy practice.
At RxConnexion, we are dedicated to supporting community pharmacies in their growth and development. While we focus on creating technology that enhances the patient experience and improves outcomes for independent pharmacies, we also prioritize staying up-to-date with the myriad aspects of running a pharmacy in 2024.
Here’s our comprehensive overview of the key changes to pharmacy and healthcare policy in 2024 and how your practice can ensure compliance:
Updates to Drug Pricing and Reimbursement
Effective at the start of 2024, the Centers for Medicare and Medicaid Services (CMS) has implemented a significant modification to the Medicare Part D plan. This change mandates that all Direct and Indirect Remuneration (DIR) Fees be included at the point of sale.
This update means pharmacies will no longer be billed retroactively for these fees, which previously could occur up to six months later. While this change aims to bring more transparency and predictability to pharmacy reimbursements, it has also led to higher DIR fees and lower point-of-sale (POS) reimbursements during the transition period. Independent pharmacies need to adjust their financial planning and cash flow management to navigate this new landscape effectively.
Telehealth Regulations and Opportunities
With the increased adoption of telehealth services during the COVID-19 pandemic, many temporary regulations have become permanent. In 2024, there are new compliance requirements for telehealth services, including stricter patient consent processes, enhanced data privacy measures, and more detailed documentation standards. Pharmacies offering telemedicine services, such as XPedicareRx-24, must stay informed about these regulations to avoid penalties and ensure they are providing the highest standard of care.
Compounding Pharmacy Regulations
Compounding pharmacies face rigorous scrutiny to ensure the safety and quality of customized medications. In 2024, there are updated guidelines from the U.S. Pharmacopeia (USP) and the Food and Drug Administration (FDA) that impact how compounded medications are prepared, stored, and dispensed. Pharmacies must ensure their compounding processes align with these new standards, which may include adjustments to facilities, training for staff, and updated record-keeping practices.
Controlled Substances Monitoring
The opioid crisis continues to drive changes in the regulations surrounding controlled substances. In 2024, new policies have been introduced to enhance the monitoring and reporting of controlled substance prescriptions. Pharmacies must implement robust systems to track prescriptions accurately, ensure compliance with state prescription drug monitoring programs (PDMPs), and educate patients about the risks associated with controlled substances.
Pharmacy Licensing and Credentialing
Maintaining proper licensing and credentialing is crucial for pharmacy operations. In 2024, there are updates to the requirements for pharmacy licenses, including continuing education mandates and stricter criteria for renewals. Pharmacies must keep track of these changes and ensure all staff members meet the necessary qualifications and training to maintain compliance.
Staying current with the evolving regulatory landscape is essential for the success of independent pharmacies. At RxConnexion, we are committed to helping you navigate these changes, providing the tools and resources you need to remain compliant and thrive in 2024. By staying informed and proactive, your pharmacy can continue to deliver exceptional care to your patients while adhering to the latest regulations.
To learn more or get other resources available through RxConnexion visit our website at:
Comments